H

Harmonex Neuroscience Research | Dothan, AL

Research site
(Unclaimed)
Location
408 Healthwest Drive, Dothan, Alabama, United States of America

Site insights

Top conditions

Top treatments

Lurasidone
Rapastinel
SHP465
SPN-812
Viloxazine
Lithium
Aripiprazole
Vilazodone
Guanfacine HCl
Divalproex

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 39 total trials

A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)

The main aim of this study is learn more about long-term TAK-503 treatment in children and teenagers with ADHD for whom earlier stimulant treatment d...

Active, not recruiting
Attention Deficit Hyperactivity Disorder
Drug: Guanfacine hydrochloride (TAK-503)
Other: Placebo

The purpose of this study is to establish the potential benefits, safety, and tolerability of AB-2004 in participants with irritability associated wi...

Active, not recruiting
Autism Spectrum Disorder (ASD)
Drug: Placebo
Drug: AB-2004
Locations recently updated

This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults...

Enrolling
Tourette Disorder
Drug: Ecopipam Hydrochloride

ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and ad...

Enrolling
Autism Spectrum Disorder
Drug: ML-004 Placebo
Drug: ML-004 (IR)/(ER) tablet

ML-004-003 is a multi-center, open-label extension study that will enroll approximately 120 adolescent and adult subjects with ASD that have complete...

Invitation-only
Autism Spectrum Disorder
Drug: ML-004 (IR)/(ER) tablet

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Enrolling
Bipolar I Disorder
Schizophrenia
Drug: Cariprazine Flexible Dose

Trial sponsors

Shire logo
Sumitomo Pharma logo
Allergan logo
E
Roche logo
Forest Laboratories logo
M
Supernus Pharmaceuticals logo
AbbVie logo
Akili Interactive Labs logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems